References
- Alves, P., & Winstock, A. (2011). Patients knowledge about treatment for opioid dependence. The Psychiatrist, 35, 448–453
- Department of Health. (1999). Drug misuse and dependence – Guidelines on clinical management. Department of Health (England), The Scottish Office Department of Health, Welsh Office and Department of Health and Social Services, Northern Ireland
- Department of Health. (2007). Drug misuse and dependence – Guidelines on clinical management. Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Irish Executive
- Department of Health and Human Services. (2002). Methadone maintenance treatment. Atlanta, GA: Department of Health and Human Services, Centre for Disease Control
- Egan, J., Netherland, J., Gass, J., Finkelstein, R., & Weiss, L., for the BHIVES Collaborative. (2011). Patient perspectives on Buprenorphine/Naloxone treatment in the context of HIV care. Journal of Acquired Immune Deficiency Syndrome, 56, S46–S53
- Fiellin, D. A., Pantalon, M., Chawarski, M. C., Moore, B. A., Sullivan L. E.’ O’Connor, P. G., & Schottenfeld R. S. (2006). Counselling plus buprenorphine-naloxone for opioid dependence. New England Journal of Medicine, 355, 365–374
- Ford, C., Halliday, K., Lawson, E., & Browne, E. (2011). Guidance for the use of substitute prescribing in the treatment of opioid dependence in primary care. London: Royal College of General Practitioners
- Ford, C., Morton, S., Lintzeriz, L., Bury, J., & Gerada, C. (2004). Guidance for the use of buprenorphine for the treatment of opioid dependence in primary care. Manchester: Royal College of General Practitioners
- James, L., & Clark, D. (2011). Methadone versus subutex: Recovering heroin users’ views on substitute prescribing. Swansea, UK: Swansea University
- Lanarkshire Alcohol and Drug Action Team. (2008). Lanarkshire alcohol and drug action team delivery plan 2008–2011. Hamilton: Lanarkshire ADAT
- McKeganey, N., Russell, C., & Cockayne, L. (2013). Medically assisted recovery within the context of the UK drug strategy: Methadone and suboxone (buprenorphine-naloxone) patients compared. Journal of Substance Abuse Treatment, 44, 97–102
- National Institute for Health and Clinical Excellence (NICE). (2007). Methadone and buprenorphine for the management of opioid dependence. London. Available at: http://www.nice.org.uk/TA114 [last accessed 24 Dec 2013]
- National Treatment Agency for Substance Misuse. (2003). Prescribing service for drug misuse. London: National Treatment Agency
- NHS National Services Scotland. (2010). Drug Misuse Statistics Scotland 2010. Edinburgh. Available at: http://www.drugmisuse.isdscotland.org/publications/10dmss/10dmssb.htm [last accessed 4 Nov 2011]
- NICE guideline. (2008). Drug misuse: Opioid detoxification. Leicester: The British Psychological Society. Available at: http://guidance.nice.org.uk/CG52/Guidance/pdf/English [last accessed 12 Nov 2011]
- Pinto, H., Rumball, D., & Holland, R. (2008). Attitude and knowledge of substance misusers regarding buprenorphine and methadone maintenance therapy. Journal of Substance Use, 13, 143–153
- Rapeli, P., Fabritius, C., Alho, H., Salaspuro, M., Wahlbeck, K., & Kalska, H. (2007). Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls. BMC Clinical Pharmacology, 7, 5
- Scottish Government. (2008). The road to recovery: A new approach to tackling Scotland’s drug problem. Edinburgh. Available at: http://www.scotland.gov.uk/Publications/2008/05/22161610/0 [last accessed 4 Nov 2011]
- Scottish Government. (2011). National Forum on Drug-Related Deaths in Scotland – Annual Report 2010–11. Available at: http://www.scotland.gov.uk/Publications/2011/11/09091958/4 [last accessed 28 Nov 2011]
- Tanner, G. R., Bordon, N., Conroy, S., & Best, D. (2011). Comparing methadone and suboxone in applied treatment settings: The experiences of maintenance patients in Lanarkshire. Journal of Substance Use, 16, 171–178
- Yokell, M., Zaller, N., Green, T., & Rich, J. (2011). Buprenorphine and buprenorphine/naloxone diversion, misuse and illicit use: An international review. Current Drug Abuse Reviews, 4, 28–41